Bentley Pharmaceuticals to Release First-Quarter 2008 Financial Results on May 8, 2008

  
    
  
  
    
      Bentley Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical 
      company, today announced that management will host a conference call to 
      discuss first-quarter 2008 financial results on Thursday, May 8, 2008, 
      at 10:00 a.m. (ET). On the call, the Company will also provide an update 
      on the ongoing process of separating its drug delivery business from its 
      generic pharmaceuticals business. Bentley will release its results for 
      the three months ended March 31, 2008, before the market opens on that 
      day.
    
    
      To participate on the live call, please dial [phone] or (973) 
      582-2856 for international callers. The access code for the call is 
      45706774. The conference call will also be webcast live and may be 
      accessed via Bentley’s website, www.bentleypharm.com.
    
    
      A telephone replay will be available for 30 days by dialing (800) 
      642-1687 or [phone] for international callers. Please reference 
      reservation number 45706774. A replay of the conference call also will 
      be available on Bentley’s website for 30 days.
    
    
      Bentley Pharmaceuticals, Inc. is a specialty pharmaceutical company 
      focused on advanced drug delivery technologies and generic 
      pharmaceutical products. Bentley's proprietary drug delivery 
      technologies enhance the absorption of pharmaceutical compounds across 
      various membranes. Bentley manufactures and markets a growing portfolio 
      of generic and branded generic pharmaceuticals in Europe for the 
      treatment of cardiovascular, gastrointestinal, infectious and central 
      nervous system diseases through its subsidiaries -- Laboratorios Belmac, 
      Laboratorios Davur, Laboratorios Rimafar and Bentley Pharmaceuticals 
      Ireland. Bentley also manufactures and markets active pharmaceutical 
      ingredients through its subsidiary, Bentley API.
    
    
      Additional information regarding Bentley Pharmaceuticals may be obtained 
      through Bentley's website at www.bentleypharm.com.